News & Press

LEARN ABOUT CorriX™

Press Releases

10.05.2016

Avitop Obtains US and EU Authorization for Nutraceutical CorriX™ and Announces Product Launch

Berlin, Germany, October 12, 2015 – Avitop GmbH, a Berlin-based biotech company developing next generation nutraceuticals, announced today that the Company has obtained European Novel Food authorization from the European Commission for CorriX™, a nutraceutical containing the Company’s proprietary strain Bacteroides xylanisolvens DSM 23964 under Regulation (EC) No 258/97 of the European Parliament and of the Council.

Read more

Contact us

Contact us